DEGRO practical guideline for partial-breast irradiation.

Brachytherapy / methods Breast / radiation effects Breast Neoplasms / radiotherapy Female Germany Humans Patient Selection Radiotherapy Dosage Societies, Medical
APBI Breast cancer Early breast cancer Guideline Partial breast irradiation

Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 20 02 2020
accepted: 19 03 2020
pubmed: 1 5 2020
medline: 15 12 2020
entrez: 1 5 2020
Statut: ppublish

Résumé

This consensus statement from the Breast Cancer Working Group of the German Society for Radiation Oncology (DEGRO) aims to define practical guidelines for accelerated partial-breast irradiation (APBI). Recent recommendations for relevant aspects of APBI were summarized and a panel of experts reviewed all the relevant literature. Panel members of the DEGRO experts participated in a series of conferences, supplemented their clinical experience, performed a literature review, and formulated recommendations for implementing APBI in clinical routine, focusing on patient selection, target definition, and treatment technique. Appropriate patient selection, target definition for different APBI techniques, and basic rules for appropriate APBI techniques for clinical routine outside of clinical trials are described. Detailed recommendations for APBI in daily practice, including dose constraints, are given. Guidelines are mandatory to assure optimal results of APBI using different techniques.

Identifiants

DOI: 10.1007/s00066-020-01613-z PMID: 32350554 PMC: PMC7449998
pubmed: 32350554
doi: 10.1007/s00066-020-01613-z
pii: 10.1007/s00066-020-01613-z
pmc: PMC7449998
doi:

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

749-763

Références

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):614-21
pubmed: 26461003
Radiother Oncol. 2013 Aug;108(2):197-202
pubmed: 23742961
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):55-64
pubmed: 27511847
Lancet. 2019 Dec 14;394(10215):2165-2172
pubmed: 31813635
Lancet. 2014 May 17;383(9930):1716
pubmed: 24835608
Radiother Oncol. 2019 Mar;132:85-92
pubmed: 30825975
Radiother Oncol. 2009 Jan;90(1):1-13
pubmed: 18783840
Breast J. 2007 Nov-Dec;13(6):575-80
pubmed: 17983399
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):275-82
pubmed: 19362247
Curr Oncol Rep. 2008 Jan;10(1):54-60
pubmed: 18366961
Lancet. 2016 Apr 23;387(10029):1717-8
pubmed: 27116273
Lancet Oncol. 2018 Jun;19(6):834-844
pubmed: 29695348
Breast J. 2019 Jan;25(1):124-128
pubmed: 30525258
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):806-13
pubmed: 22245196
Radiother Oncol. 2018 Sep;128(3):428-433
pubmed: 29914648
Radiother Oncol. 2013 Jan;106(1):21-7
pubmed: 23218711
Lancet. 2016 Jan 16;387(10015):229-38
pubmed: 26494415
Lancet Oncol. 2017 Feb;18(2):259-268
pubmed: 28094198
Breast Care (Basel). 2018 Jul;13(3):162-167
pubmed: 30069175
Br J Cancer. 2004 Apr 5;90(7):1343-8
pubmed: 15054452
Front Radiat Ther Oncol. 2007;40:253-271
pubmed: 17641514
Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):17-21
pubmed: 8083111
Clin Adv Hematol Oncol. 2006 Oct;4(10):719-21
pubmed: 17111558
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):568-74
pubmed: 21570210
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):910-6
pubmed: 22543213
Radiother Oncol. 2014 Jan;110(1):199-212
pubmed: 24299968
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e145-52
pubmed: 22543201
Radiother Oncol. 2016 Jan;118(1):199-204
pubmed: 26776444
Ann Surg Oncol. 2013 Oct;20(10):3279-85
pubmed: 23975302
Lancet. 2019 Dec 14;394(10215):2155-2164
pubmed: 31813636
J Clin Oncol. 2013 Nov 10;31(32):4038-45
pubmed: 23835717
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):987-1001
pubmed: 19545784
Radiother Oncol. 2010 Mar;94(3):264-73
pubmed: 20181402
Radiother Oncol. 2010 Mar;94(3):274-9
pubmed: 20181401
Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):506-8
pubmed: 25304946
Eur J Cancer. 2001 Nov;37(17):2178-83
pubmed: 11677104
Radiol Oncol. 2019 Jan 19;53(1):123-130
pubmed: 30661060
Radiother Oncol. 2018 Sep;128(3):411-420
pubmed: 29691075
Brachytherapy. 2018 Nov - Dec;17(6):956-965
pubmed: 30236908
Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):363-72
pubmed: 10661343
J Clin Oncol. 2009 Jan 1;27(1):16-23
pubmed: 19018080
Ann Surg Oncol. 2016 Jun;23(6):1796-8
pubmed: 26903044
Am J Surg. 2000 Oct;180(4):299-304
pubmed: 11113440
Brachytherapy. 2013 Jul-Aug;12(4):267-77
pubmed: 23619524
Brachytherapy. 2016 Nov - Dec;15(6):780-787
pubmed: 27528591
Lancet. 2005 Dec 17;366(9503):2087-106
pubmed: 16360786
Eur J Cancer. 2015 Mar;51(4):451-63
pubmed: 25605582
Br J Cancer. 2018 Aug;119(4):389-407
pubmed: 30061587
Front Radiat Ther Oncol. 2011;43:292-314
pubmed: 21625159
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):264-9
pubmed: 23433798
Radiother Oncol. 2015 Jun;115(3):342-8
pubmed: 26104975
Lancet Oncol. 2013 Dec;14(13):1269-77
pubmed: 24225155
Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):491-7
pubmed: 26068479
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):17-24
pubmed: 20605365
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):951-952
pubmed: 26194661
Lancet. 2016 Jan 16;387(10015):201-2
pubmed: 26494414
Ann Surg Oncol. 2014 Nov;21(12):3793-9
pubmed: 25138079
Lancet. 2014 Feb 15;383(9917):603-13
pubmed: 24224997
Phys Med. 2019 Jul;63:70-78
pubmed: 31221412
J Clin Oncol. 2003 Feb 1;21(3):555-63
pubmed: 12560449
Radiother Oncol. 2011 Aug;100(2):189-94
pubmed: 20673690
Strahlenther Onkol. 2019 Aug;195(8):767-768
pubmed: 31001645
Br J Cancer. 2017 Jul 11;117(2):179-188
pubmed: 28588320
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):338-48
pubmed: 26853342
Brachytherapy. 2018 Jan - Feb;17(1):40-49
pubmed: 28869144
Ann Surg Oncol. 2011 Feb;18(2):453-8
pubmed: 20737219
Eur J Surg Oncol. 2009 Jun;35(6):578-82
pubmed: 18938055
Strahlenther Onkol. 2019 Jan;195(1):1-12
pubmed: 30310926
Radiat Oncol. 2018 Mar 23;13(1):49
pubmed: 29566762
Lancet. 2017 Sep 9;390(10099):1048-1060
pubmed: 28779963
Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):255-7
pubmed: 25636752
J Clin Oncol. 1991 Sep;9(9):1662-7
pubmed: 1875223
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1051-7
pubmed: 24161420
Health Technol Assess. 2016 Sep;20(73):1-188
pubmed: 27689969
Strahlenther Onkol. 2019 Jul;195(7):640-647
pubmed: 30796496
Pract Radiat Oncol. 2017 Mar - Apr;7(2):73-79
pubmed: 27866865
J Am Coll Surg. 2009 Aug;209(2):269-77
pubmed: 19632605
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):606-11
pubmed: 22494589
Radiat Oncol. 2018 Apr 13;13(1):68
pubmed: 29653541
Breast Cancer Res Treat. 2002 Jul;74(1):77-94
pubmed: 12150455
Front Oncol. 2016 May 23;6:129
pubmed: 27242967

Auteurs

V Strnad (V)

University Hospital Erlangen, Erlangen, Germany. vratislav.strnad@uk-erlangen.de.

D Krug (D)

University Hospital Schleswig-Holstein, Kiel, Germany.

F Sedlmayer (F)

Paracelsus Medical University Hospital Salzburg, Salzburg, Austria.

M D Piroth (MD)

Helios University Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany.

W Budach (W)

Heinrich-Heine-University Hospital Düsseldorf, Düsseldorf, Germany.

R Baumann (R)

St. Marien-Krankenhaus Siegen, Siegen, Germany.

P Feyer (P)

Vivantes Hospital Neukoelln, Berlin, Germany.

M N Duma (MN)

University Hospital, Jena, Germany.

W Haase (W)

St.-Vincentius-Hospital Karlsruhe, Karlsruhe, Germany.

W Harms (W)

St. Claraspital Basel, Basel, Switzerland.

T Hehr (T)

Marienhospital Stuttgart, Stuttgart, Germany.

R Fietkau (R)

University Hospital Erlangen, Erlangen, Germany.

J Dunst (J)

University Hospital Schleswig-Holstein, Kiel, Germany.

R Sauer (R)

University Hospital Erlangen, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Radiothérapie › Curiethérapie › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Régions du corps › Région mammaire › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Régions géographiques › Europe › Allemagne › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Sélection de patients › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Dosimétrie en radiothérapie › DEGRO practical guideline for partial-breast...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Sociétés › Sociétés médicales › DEGRO practical guideline for partial-breast...